MYL3

myosin light chain 3, the group of Myosin light chains, class 1

Basic information

Region (hg38): 3:46835110-46882178

Links

ENSG00000160808NCBI:4634OMIM:160790HGNC:7584Uniprot:P08590AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypertrophic cardiomyopathy 8 (Strong), mode of inheritance: AD
  • hypertrophic cardiomyopathy 8 (Definitive), mode of inheritance: AD
  • dilated cardiomyopathy (Disputed Evidence), mode of inheritance: AD
  • arrhythmogenic right ventricular cardiomyopathy (Limited), mode of inheritance: AD
  • hypertrophic cardiomyopathy (Definitive), mode of inheritance: AD
  • hypertrophic cardiomyopathy 8 (Strong), mode of inheritance: AD
  • hypertrophic cardiomyopathy 8 (Strong), mode of inheritance: Semidominant

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cardiomyopathy, familial hypertrophic, 8AD/ARCardiovascularEarly recognition may allow preventive measures and early medical management, which may ameliorate severe sequelaeCardiovascular6211078; 8673105; 12021217; 16267253; 21239446; 21896538

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYL3 gene.

  • Hypertrophic_cardiomyopathy (351 variants)
  • Cardiomyopathy (144 variants)
  • Cardiovascular_phenotype (133 variants)
  • not_provided (102 variants)
  • not_specified (60 variants)
  • Hypertrophic_cardiomyopathy_8 (46 variants)
  • Primary_familial_hypertrophic_cardiomyopathy (13 variants)
  • MYL3-related_disorder (11 variants)
  • Dilated_cardiomyopathy_1U (2 variants)
  • Amyloidosis,_hereditary_systemic_1 (1 variants)
  • Restrictive_cardiomyopathy (1 variants)
  • Long_QT_syndrome (1 variants)
  • Increased_left_ventricular_wall_thickness (1 variants)
  • Hypertrophic_cardiomyopathy_1 (1 variants)
  • Cardiomyopathy,_familial_restrictive,_1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYL3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000258.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
81
clinvar
4
clinvar
89
missense
1
clinvar
15
clinvar
220
clinvar
6
clinvar
242
nonsense
2
clinvar
2
start loss
1
3
4
frameshift
2
clinvar
16
clinvar
18
splice donor/acceptor (+/-2bp)
1
clinvar
12
clinvar
13
Total 1 19 257 87 4

Highest pathogenic variant AF is 0.000051427

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYL3protein_codingprotein_codingENST00000395869 624298
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.08790.875125741071257480.0000278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.756921150.8010.000006991300
Missense in Polyphen2438.50.62337460
Synonymous-0.9595143.01.190.00000269364
Loss of Function1.7838.640.3473.77e-7115

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001230.000123
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00003530.0000352
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulatory light chain of myosin. Does not bind calcium.;
Disease
DISEASE: Cardiomyopathy, familial hypertrophic 8 (CMH8) [MIM:608751]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Rarely, patients present a variant of familial hypertrophic cardiomyopathy, characterized by mid-left ventricular chamber thickening. {ECO:0000269|PubMed:12021217, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:23594557, ECO:0000269|PubMed:8673105}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cardiac muscle contraction - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Apelin signaling pathway - Homo sapiens (human);Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin;Striated Muscle Contraction;Regulation of Actin Cytoskeleton;Striated Muscle Contraction;Muscle contraction (Consensus)

Recessive Scores

pRec
0.227

Intolerance Scores

loftool
0.218
rvis_EVS
-0.38
rvis_percentile_EVS
27.42

Haploinsufficiency Scores

pHI
0.0778
hipred
Y
hipred_score
0.875
ghis
0.537

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.830

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Myl3
Phenotype

Gene ontology

Biological process
regulation of the force of heart contraction;regulation of striated muscle contraction;skeletal muscle tissue development;muscle filament sliding;positive regulation of ATPase activity;ventricular cardiac muscle tissue morphogenesis;cardiac muscle contraction
Cellular component
cytosol;muscle myosin complex;sarcomere;A band;I band
Molecular function
motor activity;actin monomer binding;calcium ion binding;structural constituent of muscle;myosin II heavy chain binding